Summit Global Investments’s Transmedics TMDX Stock Holding History

Summit Global Investments’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,260	Closed	-$397K	–	534
2025 Q4	$397K	Buy	3,260 +112	+4%	+$14.1K	0.02%	376
2025 Q3	$353K	Buy	+3,148	New	+$368K	0.02%	367
2023 Q3	–	Sell	-5,022	Closed	-$422K	–	610
2023 Q2	$422K	Buy	+5,022	New	+$384K	0.03%	373
2021 Q3	–	Sell	-7,700	Closed	-$255K	–	564
2021 Q2	$255K	Buy	+7,700	New	+$213K	0.02%	488

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Summit Global Investments's TMDX Position: Q1 2026 in Review

Summit Global Investments sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 3,260 shares — an estimated $397K sold.

Summit Global Investments first reported a position in TMDX in Q2 2021 and held it in 4 quarters. The position peaked at $422K in Q2 2023. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Summit Global Investments reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
Summit Global Investments sold 3,260 Transmedics shares in Q1 2026, an estimated $397K.
Summit Global Investments first reported a position in Transmedics in Q2 2021 and held it in 4 quarters.
Summit Global Investments's Transmedics position peaked at $422K in Q2 2023.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Summit Global Investments's 13F filing for Q1 2026, filed 7 May 2026.